Navigation Links
PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009
Date:10/30/2009

RALEIGH, N.C., Oct. 30 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that its experts will present at a session during the 8th Annual Partnerships in Clinical Trials 2009 to be held 4 - 5 November 2009 at the World Trade Centre in Rotterdam, The Netherlands. PRA operational and therapeutic leaders are also attending the conference. PRA is exhibiting at booth number 32.

On 4 November, PRA's Christian Tucat, Senior Vice President of Business Development, Europe participates in a session entitled Emerging markets: Where next? In this session, Edward C. Ian, Senior Director of Clinical Operations, Asia-Pacific will share his expertise in conducting studies in emerging regions. Mr. Ian will also discuss the industry's move to emerging regions. The main focus of his presentation will be on the evolved Asia region; however, he will provide an overview of other emerging markets (i.e., Latin America, Africa and the Middle East). Drawing on his current experiences, he will discuss the regional benefits and challenges and offer practical advice on taking a systematic approach to country selection and site identification.

At PRA, Mr. Ian heads clinical operations for India, Singapore, China, Hong Kong, Korea, Australia, and Taiwan as well as PRA's International Partner Program. Mr. Ian has more than 14 years experience in clinical research.

As the head of European sales for PRA, Mr. Tucat's main responsibility is to serve PRA's clients in Europe ensuring customer satisfaction and building long-term partnerships with both existing and new clients. Mr. Tucat has worked in the pharmaceutical industry for over 11 years.

About PRA International

PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in oncology, neurosciences, respiratory/allergy, cardiovascular and infectious diseases. PRA has supported over 2,100 clinical trials through its 36 global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development life cycle.

To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International


'/>"/>
SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Mettler-Toledo International Inc. Reports Third Quarter 2009 Results
2. OC-Based Charity Teams with International Relief Organization in Holiday Fundraising Drive
3. Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego
4. Quark Pharmaceuticals Expands International Patent Protection for Compounds Targeting the RTP801 Gene
5. Chindex International, Inc. to Report Second Quarter Fiscal 2010 Financial Results
6. University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President, International Sales
7. Yongye International Announces Completion of Restructuring
8. Medizone International Announces Third Round of AsepticSure
9. With Flu Season Underway, International SOS to Host H1N1 Update Webinar
10. Ethicon Endo-Surgery Wins Prestigious International Design Award for Innovative Development of HARMONIC FOCUS(TM)
11. Fora Care Group Becomes Pioneering Educational Member of the International Society of Vascular Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") ... is pleased to announce that its majority-owned subsidiary, ... U.S. Food and Drug Administration (FDA) for the ... tablets in the 12.5 mg and 25 mg ... equivalent of the branded product Xenazine ® ...
(Date:3/23/2017)... ReNeuron reported in December 2016 positive ... stroke patients, despite not meeting the three-month time frame of ... Research Arm Test (ARAT). As a result, the company has ... study in 2017. Beyond CTX, we expect safety and efficacy ... Phase I data from its critical limb ischaemia (CLI) trial. ...
(Date:3/23/2017)... , Mar 23, 2017 The Board ... to the Annual General Meeting, which is to take place on ... 2 in Lund, Sweden . ... Please see the attached notification, which ... Inrikes Tidningar. NeuroVive Pharmaceutical AB (Publ) The Board Of ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... , ... The American Board of Quality Assurance and Utilization Review Physicians (ABQAURP) ... Health Care Quality and Management and Patient Safety. , It is with appreciation and ... also to the Health Care Quality and Patient Safety movements. Diplomates and Members lead ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... and the New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April ... , How will the new EU MDR language change the way manufacturers ...
(Date:3/23/2017)... ... , ... “Beyond and Back”: a true-life testimony of tragedy and the miraculous ... Bonetta Rose, a wife, mother and grandmother committed to sharing her many spiritual adventures ... Rose‘s new book presents actual events in the life of her family, which validate ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... the existence of God. “A Respectful Response To Atheist Manifesto” is the creation ... married to his wife, Nancy, for sixty years. He holds graduate degrees from ...
(Date:3/22/2017)... ... March 23, 2017 , ... Death anxiety is unconscious ... profession, author Joy Nugent was inspired to write the book titled “ As Good ... inward desire to make sense of what she was experiencing at the bedside of ...
Breaking Medicine News(10 mins):